A Phase II, Randomized, Placebo-Controlled, Double Blind, Trial of Safety, Tolerability and Efficacy Study of Topical AKP-11 Administration to Participants with Arthritis.
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2019
Price : $35 *
At a glance
- Drugs AKP 11 (Primary)
- Indications Arthritis; Gout; Osteoarthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Akaal Pharma
- 07 Aug 2018 Status changed from not yet recruiting to recruiting.
- 23 Aug 2017 New trial record